Scientist lets snakes bite him 200 times to create 'unique' antidote

This undated photo provided by Centivax in 2025 shows Tim Friede, who is hyperimmune to the venom of various snakes, with a water cobra coiled around his arm. (Centivax via AP)
Tim frequently exposed himself to poison that was so dangerous it could kill a horse (Photo: AP)

Scientist injected himself with deadly poison more than 850 times to produce a 'unique' antidote in his blood.

Over the course of 18 years, Tim Friede allowed himself to be bitten by poisonous snakes more than 200 times, and even fell into a coma after two cobra bites.

His mission was to develop immunity to snake bites so that scientists could create a universal antidote.

Tim constantly exposed himself to poison that could kill a horse, and it looks like all his efforts paid off.

In this photo provided by Centivax, Tim Friede, center, stands in a lab in South San Francisco, California, in 2023, where his blood is used to prepare an antidote for various snake bites. (Centivax via AP)
Tim with researchers who developed new antidotes from his blood (Photo: AP)

Researchers have used his blood to create an innovative treatment for snake bites.

Each year, snake bites kill up to 140,000 people, and more than 420,000 are left disabled or require amputation.

The high incidence rate is due to the lack of a universal antivenom for all types of snake bites.

His project started on YouTube, where he created a channel dedicated to snakes.

The scientist hoped to develop his own immunity to snake bites so that he could interact with the dangerous reptiles for video filming.

However, his plan failed at the very beginning when, in 2001, two bites from an Egyptian cobra left him fighting for his life.

Tim told the BBC about his coma: “I didn't want to die. I didn't want to lose my finger. I didn't want to miss work.”

“It became a way of life and I kept trying, trying my best – for the people who were 8,000 miles away and dying from snake bites.”

Chief herpetologist Geoffrey Maranga (R) receives assistance in controlling an Egyptian cobra while extracting venom from various snake species for use in research into local production of antivenom at the Kenya Snakebite Intervention and Research Centre at the Kenya Primate Research Institute (KIPRE) in Nairobi on March 7, 2025. Snakebite envenoming has been classified as a Category A neglected tropical disease by the World Health Organization (WHO) due to its high morbidity and mortality. Africa is among other regions with low or no access to antivenom therapy. The Snakebite Research and Intervention Centre at the Kenya Institute of Primate Research (KIPRE) aims to research and develop antivenom locally, a first in Kenya and East Africa, which have relied heavily on imported antivenom, mainly from Mexico and India, despite its widespread ineffectiveness as treatments in one region are often ineffective in treating snakebites in another region. (Photo by Tony Karumba/AFP) (Photo by TONY Karumba/AFP via Getty Images)
Two bites from an Egyptian cobra left Tim in a coma in 2001 (Photo: Tony Karumba/AFP)

Antidote researchers soon learned of Tim's activities and contacted him.

Dr Jacob Glanville, chief executive of biotech company Centivax, said: “I thought, 'This might sound weird, but I'd be happy to take some of your blood.'”

Until this point, antidotes were produced only by injecting small doses of the poison into animals such as horses.

As a result, the animal produced antibodies to fight the poison, and the researchers collected these antibodies for further use.

However, this strategy was limited by the huge variety of toxins released by the bites of different species of venomous snakes.

This meant that the poison and antidote had to be

Sourse: metro.co.uk

Leave a Reply

Your email address will not be published. Required fields are marked *